Bethesda (1)

Advanced Solid Tumor (1)

High Grade Neuroendocrine Cancers (1)

SCLC (1)

Small Cell Cancer (1)

Recruiting (1)

phase 1/phase 2 (1)

National Cancer Institute (NCI) (1)

berzosertib (1)

lurbinectedin (1)

drug (1)

NIH (1)

Interventional (1)

small cell cancer

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Jan 20, 2023